bioRxiv · 10.1101/2025.08.07.668901
Nanobubbles for Precision Oncology: Preclinical Evaluation of Molecular Targeted Ultrasound Contrast Agents in a Rabbit Model
Abstract
The localization of prostate cancer by ultrasound remains limited by the lack of B-mode conspicuity and the confinement of clinically approved microbubbles (MBs) to the vasculature. This precludes the differentiation of viable tumor tissue, necrotic tissue, and margin-associated disease. We investigate the use of prostate-specific membrane antigen (PSMA)-targeted lipid-shelled perfluorocarbon nanobubbles (PSMA-NBs) in an orthotopic rabbit model using a clinical CEUS system. We implanted PSMA-positive PC3pip-GFP tumors into the prostates of immunosuppressed New Zealand White rabbits and performed transabdominal imaging with PSMA-NBs, MBs, and untargeted nanobubbles (Plain-NB) using the same imaging and analysis protocols. To address tumor heterogeneity and ultrasound boundary ambiguity, ROIs were defined from baseline B-mode images and segmented into the tumor core, rim, and a surrounding peritumoral area. Pixel-wise parametric and decorrelation time (DT) maps were generated and correlated with whole-slide histology (H&E) and PSMA IHC. Compared to MBs, PSMA-NBs exhibited higher peak intensities in the tumor core and rim (1.60-fold and 1.50-fold, respectively) and improved retention (mean transit time: 4.20 to 4.50-fold higher) for up to 10 minutes in the tumor and peritumoral areas. PSMA-NB kinetic and DT parameters also correlated with histology-defined tumor viability and PSMA expression. Compared to Plain-NBs, PSMA-NBs also exhibited improved retention (MTT +21%; AUCwo) in the rim and peritumoral areas. This study demonstrates the capability of PSMA-NBs to characterize prostate cancer by molecular CEUS beyond what is possible with conventional MBs.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Berg, F. M., Abenojar, E. C., Nittayacharn, P., Hoggard, N., Tavri, S., Matsunaga, F., Cooley, M. B., Wegierak, D., Wang, X., Rosol, T., Basilion, J. P., Exner, A. A.. 2025-08-10. Nanobubbles for Precision Oncology: Preclinical Evaluation of Molecular Targeted Ultrasound Contrast Agents in a Rabbit Model. https://doi.org/10.1101/2025.08.07.668901
Cite the original work for its findings. Save a collection to share your selection of sources.